Dechert served as legal counsel to Aquestive Therapeutics, Inc., while Cooley acted for the underwriters on the offering. Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. advised EIP Pharma, while Dechert LLP advised Diffusion Pharmaceuticals on the deal. Diffusion Pharmaceuticals Inc. announced a proposed...
You must be a Standard 1 Year member to access this content.
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented J.P. Morgan as dealer manager and arranger. Ashurst, Stibbe, Davis Polk, Schoenherr and Norton Rose Fulbright advised an ad hoc group of lenders....
You must be a Standard 1 Year member to access this content.
Dechert advised Cerus Endovascular Limited on the deal. Cerus Endovascular Limited (together with its sole subsidiary, Cerus) announced its negotiated sale to Stryker Corporation, by way...
You must be a Standard 1 Year member to access this content.
Loeb & Loeb acted as legal advisor to AGBA Acquisition Limited, while Dechert advised TAG Holdings Limited on the deal. TAG Holdings Limited (“TAG”) and its...
You must be a Standard 1 Year member to access this content.
Dechert advised Antios Therapeutics on the deal. Antios Therapeutics, Inc. (“Antios”) completed its $96 million Series B financing. Antios is a clinical-stage biopharmaceutical company focused on the...
You must be a Standard 1 Year member to access this content.
Brown Rudnick LLP advised Bibox on the deal. Bibox, a leading digital currency trading platform, obtained a securities class action victory. The suit had alleged violations of...
You must be a Standard 1 Year member to access this content.
